Frances and Victor Ginsberg Professor of Hematology/Oncology Professor of Internal Medicine and Urology Chief, Division of Hematology/Oncology Deputy Director for Clinical Services, UMCCC
Oncology
Dr. Kathleen A. Cooney, MD
|
|
Give Review
Kathleen A. Cooney, MD works in the field of Oncology. He researched medicine at Perelman School of Medicine at the University of Pennsylvania. He received 3 awards: "America's Top Doctors", "America's Top Doctors for Cancer" and "CMS Meaningful Use Stage 1 Certification". Kathleen A. Cooney, MD is a published doctor as well. He has 70 publications published. The latest was: Integrative molecular profiling of routine clinical prostate cancer specimens.
Publications
- Associations of prostate Cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases.
- Integrative molecular profiling of routine clinical prostate Cancer specimens.
- Mutational landscape of candidate genes in familial prostate Cancer.
- Identification of a novel germline SPOP mutation in a family with hereditary prostate Cancer.
- Prostate Cancer in young men: an important clinical entity.
- HOXB13 G84E-related Familial Prostate Cancers: A Clinical, Histologic, and Molecular Survey.
- Risk of second primary tumors in men diagnosed with prostate Cancer: A population-based cohort study.
- Statin Use and the Risk of Recurrence After Radical Prostatectomy in a Cohort of Men With Inherited and/or Early-onset Forms of Prostate Cancer.
- Association analysis of 9,560 prostate Cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate Cancer associa...
- The Prevalence of the HOXB13 G84E Prostate Cancer Risk Allele in Men Treated with Radical Prostatectomy.
- Global patterns of prostate Cancer incidence, aggressiveness, and mortality in men of african descent.
- Elevated Risk of Prostate Cancer Among Men With Lynch Syndrome.
- HOXB13 is a susceptibility gene for prostate Cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).
- Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for Prostate biopsy.
- Hypertension, obesity and prostate Cancer biochemical recurrence after radical prostatectomy.
- Identification of a novel NBN truncating mutation in a family with hereditary prostate Cancer.
- Germline mutations in HOXB13 and prostate-Cancer risk.
- Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate Cancer patients: a randomized phase II trial by the prostate Cancer clini...
- Prevalence and Correlates of Vitamin and Supplement Usage Among Men With a Family History of Prostate Cancer.
- Genome-wide association study of prostate Cancer in men of African ancestry identifies a susceptibility locus at 17q21.
- National Cancer Institute Prostate Cancer Genetics Workshop.
- Early onset prostate Cancer has a significant genetic component.
- Evidence for an association between prostate Cancer and chromosome 8q24 and 10q11 genetic variants in African American men: the Flint Men's Health Study.
- Erratum to: Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate Cancer patients: a randomized phase II trial by the prostate ...
- Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the Prostate.
- Sequence variation in the mitochondrial gene cytochrome c oxidase subunit I and prostate Cancer in African American men.
- Genome-wide linkage scan for prostate Cancer susceptibility from the University of Michigan Prostate Cancer Genetics Project: suggestive evidence for linkage at 16q23.
- Chromosome 17q12 variants contribute to risk of early-onset prostate Cancer.
- Chromosome 8q24 markers: risk of early-onset and familial prostate Cancer.
- Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate Cancer.
- Body composition and serum Prostate-specific antigen: review and findings from Flint Men's Health Study.
- Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate Cancer risk in African-American men: the Flint Men's Health Study.
- Sequence variation in alpha-methylacyl-CoA racemase and risk of early-onset and familial prostate Cancer.
- Common variation in the BRCA1 gene and prostate Cancer risk.
- Association between germline variation in the FHIT gene and prostate Cancer in Caucasians and African Americans.
- Phase II evaluation of oral estramustine, oral etoposide, and intravenous paclitaxel in patients with hormone-sensitive Prostate adenocarcinoma.
- Multiple regions within 8q24 independently affect risk for prostate Cancer.
- Features of the metabolic syndrome and prostate Cancer in African-American men.
- Association between family history of prostate and breast Cancer among African-American men with prostate Cancer.
- Truncating variants in p53AIP1 disrupting DNA damage-induced apoptosis are associated with prostate Cancer risk.
- Admixture mapping identifies 8q24 as a prostate Cancer risk locus in African-American men.
- Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate Cancer in black men.
- Dose escalation of oral vinorelbine in combination with estramustine in hormone-refractory adenocarcinoma of the Prostate.
- A common variant associated with prostate Cancer in European and African populations.
- Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate Cancer.
- APC I1307K and the risk of prostate Cancer.
- Genome-wide linkage scan for prostate Cancer aggressiveness loci using families from the University of Michigan Prostate Cancer Genetics Project.
- Clonality of sarcomatous and carcinomatous elements in sarcomatoid carcinoma of the Prostate.
- INSPstI polymorphism and prostate Cancer in African-American men.
- Identifying susceptibility genes for prostate Cancer--a family-based association study of polymorphisms in CYP17, CYP19, CYP11A1, and LH-beta.
- Decreasing age at prostate Cancer diagnosis over successive generations in prostate Cancer families.
- Hyperglycemia, obesity, and Cancer risks on the horizon.
- Longitudinal changes in lower urinary tract symptoms among a cohort of black American men: the Flint Men's Health Study.
- Truncating BRCA1 mutations are uncommon in a cohort of hereditary prostate Cancer families with evidence of linkage to 17q markers.
- Combined genome-wide scan for prostate Cancer susceptibility genes.
- Risk perception and concern among brothers of men with Prostate carcinoma.
- Association between Agent Orange and prostate Cancer: a pilot case-control study.
- Use of complementary and alternative medicine in men with family history of prostate Cancer: a pilot study.
- Genome-wide scan for prostate Cancer susceptibility genes using families from the University of Michigan prostate Cancer genetics project finds evidence for linkage on...
- Family history of prostate Cancer and relapse after definitive external beam radiation therapy.
- Prostate Cancer early detection practices among men with a family history of disease.
- Germ-line mutations of the macrophage scavenger receptor 1 gene: association with prostate Cancer risk in African-American men.
- Risk factors for lower urinary tract symptoms in a population-based sample of African-American men.
- R726L androgen receptor mutation is uncommon in prostate Cancer families in the united states.
- Relationship of serum sex-steroid hormones and Prostate volume in African American men.
- Metastatic dedifferentiated chordoma with elevated beta-hCG: a case report.
- Early onset prostate Cancer: predictors of clinical grade.
- Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of Prostate volume among Black men.
- Genome-wide association scan for variants associated with early-onset prostate Cancer.
Schools
Perelman School of Medicine University of Pennsylvania
University Mich Hosps
Conditions Treated
- Anemia
- Bladder Cancer
- Breast Cancer
- Leukocytosis
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Michigan Hospitals and Health Centers -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
University of Michigan Hospitals and Health Centers
Helpful Reviews
Similar Doctors
|
|
Dr. Attaphol Pawarode, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Phillip L. Palmbos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Monika L. Burness, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine H. Van Poznak, MD |
|
|
Dr. Assuntina G. Sacco, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Muneesh Tewari, MD
This Doctor is OpenDoctor Recommended.
|